Brantly is back on his feet -- literally -- after
receiving a last-ditch, highly experimental drug.
Another American missionary with Ebola got the
same.
Brantly's and Nancy Writebol's conditions
significantly improved after receiving the
medication, sources say. Brantly was able to walk
into Emory University Hospital in Atlanta after
being evacuated to the United States last week,
and Writebol is expected to arrive in Atlanta on Tuesday.
On July 22, Brantly woke up feeling feverish.
Fearing the worst, Brantly immediately isolated
himself. Writebol's symptoms started three days
later. A rapid field blood test confirmed the
infection in both of them after they had become
ill with fever, vomiting and diarrhea.
It's believed Brantly and Writebol, who worked
with the aid organization Samaritan's Purse,
contracted Ebola from another health care
worker at their hospital in Liberia, although the
official Centers for Disease Control and
Prevention case investigation has yet to be
released.
The experimental drug, known as ZMapp, was
developed by the biotech firm Mapp
Biopharmaceutical Inc., which is based in San
Diego.
The patients were told that the treatment
had never been tried before in a human being but
had shown promise in small experiments with
monkeys.
Questions about this new Ebola drug
According to company documents, four monkeys
infected with Ebola survived after being given the
therapy within 24 hours after infection. Two of
four other monkeys that started therapy within
48 hours after infection also survived. One
monkey that was not treated died within five days
of exposure to the virus.
Brantly and Writebol were aware of the risk of
taking a new, little-understood treatment and
gave informed consent, according to two sources
familiar with the care of the missionary workers.
In the monkeys, the experimental serum had
been given within 48 hours of infection. Brantly
didn't receive it until he'd been sick for nine days.
The medicine is a three-mouse monoclonal
antibody, meaning that mice were exposed to
fragments of the Ebola virus and then the
antibodies generated within the mice's blood
were harvested to create the medicine. It works
by preventing the virus from entering and
infecting new cells.

http://edition.cnn.com/2014/08/04/health/experimental-ebola-serum/index.html

Neocolonianism in health sector......they made the virus...they have the antivirus. One day Africans will be totally free!